PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186,516 | -37.2% | 11,182 | +4.0% | 0.00% | 0.0% |
| Q2 2023 | $297,052 | +45.3% | 10,755 | +21.0% | 0.00% | 0.0% |
| Q1 2023 | $204,378 | -35.5% | 8,886 | -33.7% | 0.00% | 0.0% |
| Q1 2022 | $317,000 | -43.8% | 13,399 | -18.7% | 0.00% | 0.0% |
| Q4 2021 | $564,000 | +100.0% | 16,489 | +3.8% | 0.00% | 0.0% |
| Q3 2021 | $282,000 | -66.3% | 15,892 | -14.7% | 0.00% | -50.0% |
| Q2 2021 | $836,000 | +110.1% | 18,621 | +21.2% | 0.00% | +100.0% |
| Q1 2021 | $398,000 | +53.1% | 15,367 | +19.4% | 0.00% | 0.0% |
| Q4 2020 | $260,000 | – | 12,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |